S SANEGENEBIO Trademark

Trademark Overview

On Wednesday, December 13, 2023, a trademark application was filed for S SANEGENEBIO with the United States Patent and Trademark Office. The USPTO has given the S SANEGENEBIO trademark a serial number of 98313504. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, December 14, 2023. This trademark is owned by Suzhou Sanegene Bio Inc.. The S SANEGENEBIO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; Oligonucleotide compounds for use in the targeted delivery of RNAi therapy; Pharmaceutical preparations for use in targeted pharmaceutical therapies for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; Chemical compounds in the form of a molecular nanoparticle complex that act as a platform for the delivery of RNA-based drugs to biological cells; drug delivery agents consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies
s sanegenebio

General Information

Serial Number98313504
Word MarkS SANEGENEBIO
Filing DateWednesday, December 13, 2023
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, December 14, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Description of MarkThe mark consists of abstract shape of letter "S" and the stylized wording "SanegeneBio".
Goods and ServicesPharmaceutical preparations for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; Oligonucleotide compounds for use in the targeted delivery of RNAi therapy; Pharmaceutical preparations for use in targeted pharmaceutical therapies for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; Chemical compounds in the form of a molecular nanoparticle complex that act as a platform for the delivery of RNA-based drugs to biological cells; drug delivery agents consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies
Pseudo MarkSANEGENE SANEGENE BIO
Indication of Colors claimedColor is not claimed as a feature of the mark.
Translation of Words in MarkThe wording "SanegeneBio" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 13, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSuzhou Sanegene Bio Inc.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSuzhou, Jiangsu 215103
CN

Trademark Events

Event DateEvent Description
Thursday, December 14, 2023NEW APPLICATION ENTERED
Monday, March 18, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 8, 2024TEAS VOLUNTARY AMENDMENT RECEIVED

Related Keywords

sanegenebio diseases pharmaceutical delivery compounds infections viral targeted preparations based therapies